comparemela.com

Latest Breaking News On - Asx emd - Page 1 : comparemela.com

Emyria Ltd s Calvert agreement is a step forward to human trials

“This preclinical work will help strengthen Emyria’s intellectual property relating to our synthetic cannabinoid platform. Importantly, this work will.

Emyria to accelerate FDA and TGA CBD registration programs with AltaSciences deal

S&P/ASX 200 rises on the back of health and tech as ASX small caps enjoy a good day out

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.